I have been watching the stock for several days, and picked up some more stock today. Biotechs require patience and the waiting isn't easy. The nice part about BOCX is that the Abbott deal gives some degree of validation of the RECAF serum technology. Getting hooked up with Abbott at this stage should be considered something of major importance. Also, the testing and FDA approval process of class I devices is relatively short compared to what a systemic product must go through. I have learned the hard way that the management of a company is another extremely important aspect. One thing that I have been watching was whether JP Turner would get BOCX hooked up with some toxic financing which can result in massive dilution. That has been about 4 months ago, and so far no financing has been announced. In your post you indicated that Moro said to "keep an eye on the company." That was certainly intended to be an encouragement to investors, and although I know we tend to want to only see things about our investments from the best possible view, it could be a big hint to stay tuned. Wishing the best on this investment to everyone.
